Please add info@sitcancer.org to your safe senders list.

Call for Comment

Announcing SITC’s Prostate Cancer Immunotherapy Guidelines
Open Review Period for Members

The Society for Immunotherapy of Cancer (SITC) announces an open comment period for a “Consensus Statement on Tumor Immunotherapy for the Treatment of Prostate Carcinoma” prior to its submission for publication. The open comment period begins July 7, 2016. Deadline for comment on this manuscript is August 7, 2016 at 5:00 pm ET. To view this statement and submit your comments, please click here.

Please consider supporting this important initiative by providing feedback on this manuscript. Your voice in the development of this Consensus Statement is critical, as it provides another opportunity for the authors to review their recommendations.

As an additional reminder, the open comment period for SITC’s guidelines for Hematologic Malignancies is also underway and will close July 20, 2016 at 5:00 pm ET. To link to the manuscript please click here.

Providing comment to these manuscripts before publication is a member benefit; therefore, you will be prompted to log in to the SITC Members Only section of the website to gain access. If you have any questions on your member status or need any assistance logging in, please contact us at 1 (414) 271-2456 or info@sitcancer.org.

Sincerely,

Tara Withington, CAE
Executive Director, Society for Immunotherapy of Cancer

Society for Immunotherapy of Cancer (SITC)
555 East Wells Street, Suite 1100 | Milwaukee, Wisconsin 53202-3823 USA
Phone: +1 414 271 2456 | Email: info@sitcancer.org

© 2016 Society for Immunotherapy of Cancer

Join us on:

      

If you do not wish to be included in our mailing list, please forward this message to info@sitcancer.org with the word "Remove" in the subject line.

Please add info@sitcancer.org to your safe senders list.